Procter Deferred Long Term Liab vs Common Stock Analysis
PG Stock | USD 167.71 4.30 2.63% |
Procter Gamble financial indicator trend analysis is much more than just breaking down Procter Gamble prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Procter Gamble is a good investment. Please check the relationship between Procter Gamble Deferred Long Term Liab and its Common Stock accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Procter Gamble. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in Procter Stock please use our How to Invest in Procter Gamble guide.
Deferred Long Term Liab vs Common Stock
Deferred Long Term Liab vs Common Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Procter Gamble Deferred Long Term Liab account and Common Stock. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Procter Gamble's Deferred Long Term Liab and Common Stock is -0.42. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Common Stock in the same time period over historical financial statements of Procter Gamble, assuming nothing else is changed. The correlation between historical values of Procter Gamble's Deferred Long Term Liab and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Procter Gamble are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Deferred Long Term Liab i.e., Procter Gamble's Deferred Long Term Liab and Common Stock go up and down completely randomly.
Correlation Coefficient | -0.42 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Common Stock
Most indicators from Procter Gamble's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Procter Gamble current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Procter Gamble. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in Procter Stock please use our How to Invest in Procter Gamble guide.At this time, Procter Gamble's Enterprise Value is most likely to increase significantly in the upcoming years.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 38.0B | 39.2B | 43.4B | 29.0B | Total Revenue | 80.2B | 82.0B | 84.0B | 59.7B |
Procter Gamble fundamental ratios Correlations
Click cells to compare fundamentals
Procter Gamble Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Procter Gamble fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 120.7B | 119.3B | 117.2B | 120.8B | 122.4B | 85.6B | |
Short Long Term Debt Total | 34.7B | 32.0B | 31.5B | 34.6B | 33.4B | 22.7B | |
Other Current Liab | 3.1B | 3.1B | 9.6B | 10.9B | 9.8B | 10.3B | |
Total Current Liabilities | 33.0B | 33.1B | 33.1B | 35.8B | 33.6B | 21.4B | |
Total Stockholder Equity | 46.5B | 46.4B | 46.6B | 46.8B | 50.3B | 37.2B | |
Property Plant And Equipment Net | 20.7B | 21.7B | 21.2B | 21.9B | 23.0B | 17.1B | |
Net Debt | 18.5B | 21.7B | 24.3B | 26.4B | 23.9B | 17.8B | |
Retained Earnings | 100.2B | 106.4B | 112.4B | 118.2B | 123.8B | 130.0B | |
Cash | 16.2B | 10.3B | 7.2B | 8.2B | 9.5B | 4.8B | |
Non Current Assets Total | 92.7B | 96.2B | 95.6B | 98.2B | 97.7B | 66.5B | |
Non Currrent Assets Other | 8.3B | 10.0B | 4.0B | 11.8B | (9.8B) | (9.3B) | |
Cash And Short Term Investments | 16.2B | 10.3B | 7.2B | 8.2B | 9.5B | 6.1B | |
Net Receivables | 4.2B | 4.7B | 5.1B | 5.5B | 6.1B | 4.6B | |
Common Stock Shares Outstanding | 2.6B | 2.6B | 2.5B | 2.5B | 2.5B | 2.3B | |
Liabilities And Stockholders Equity | 120.7B | 119.3B | 117.2B | 120.8B | 122.4B | 85.6B | |
Non Current Liabilities Total | 40.8B | 39.5B | 37.3B | 38.0B | 38.2B | 26.9B | |
Inventory | 5.5B | 6.0B | 6.9B | 7.1B | 7.0B | 5.2B | |
Other Current Assets | 2.1B | 2.1B | 2.4B | 1.9B | 2.1B | 2.8B | |
Other Stockholder Equity | (41.4B) | (50.1B) | (57.6B) | (63.2B) | (65.7B) | (62.4B) | |
Total Liab | 73.8B | 72.7B | 70.4B | 73.8B | 71.8B | 48.3B | |
Total Current Assets | 28.0B | 23.1B | 21.7B | 22.6B | 24.7B | 19.1B | |
Short Term Debt | 11.2B | 8.9B | 8.6B | 10.2B | 7.4B | 7.1B | |
Intangible Assets | 23.8B | 23.6B | 23.7B | 23.8B | 22.0B | 19.1B | |
Accounts Payable | 12.1B | 13.7B | 14.9B | 14.6B | 15.4B | 16.1B | |
Good Will | 39.9B | 40.9B | 39.7B | 40.7B | 40.3B | 37.2B | |
Property Plant And Equipment Gross | 20.7B | 21.7B | 46.7B | 48.6B | 50.1B | 52.6B | |
Accumulated Other Comprehensive Income | (17.2B) | (14.8B) | (13.1B) | (13.0B) | (12.6B) | (12.0B) | |
Current Deferred Revenue | 6.7B | 6.6B | 7.4B | 1.0B | 1.2B | 1.1B | |
Other Liab | 16.7B | 16.4B | 14.4B | 13.6B | 15.7B | 11.2B | |
Other Assets | 7.4B | 10.0B | 11.0B | 11.0B | 12.7B | 13.3B | |
Long Term Debt | 23.5B | 23.1B | 22.8B | 24.4B | 25.3B | 21.5B | |
Property Plant Equipment | 21.5B | 21.7B | 21.2B | 21.9B | 25.2B | 20.7B | |
Treasury Stock | (105.6B) | (115.0B) | (123.4B) | (129.7B) | (116.8B) | (122.6B) | |
Net Tangible Assets | (18.1B) | (17.9B) | (16.5B) | (18.5B) | (21.3B) | (22.3B) |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Procter Gamble. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in Procter Stock please use our How to Invest in Procter Gamble guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Household Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procter Gamble. If investors know Procter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procter Gamble listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.12) | Dividend Share 3.894 | Earnings Share 5.8 | Revenue Per Share 35.566 | Quarterly Revenue Growth (0.01) |
The market value of Procter Gamble is measured differently than its book value, which is the value of Procter that is recorded on the company's balance sheet. Investors also form their own opinion of Procter Gamble's value that differs from its market value or its book value, called intrinsic value, which is Procter Gamble's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procter Gamble's market value can be influenced by many factors that don't directly affect Procter Gamble's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procter Gamble's value and its price as these two are different measures arrived at by different means. Investors typically determine if Procter Gamble is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procter Gamble's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.